Table 3. Changes in routine blood test analytes between cycles (mean ± SD).
Blood test | Control group | Treated group | P value |
---|---|---|---|
WBC (×109) | |||
d1 | 2.02±1.35 | 1.20±0.97 | 0.002 |
d2 | 2.12±1.56 | 1.31±1.26 | 0.005 |
d3 | 1.86±1.84 | 1.61±1.41 | 0.447 |
d4 | 1.53±1.85 | 1.58±1.38 | 0.887 |
NEU (×109) | |||
d1 | 1.84±1.53 | 1.05±1.02 | 0.006 |
d2 | 1.87±1.39 | 1.20±1.16 | 0.010 |
d3 | 1.73±1.47 | 1.40±1.32 | 0.247 |
d4 | 1.36±1.69 | 1.34±1.22 | 0.939 |
HGB (g/L) | |||
d1 | 6.65±8.72 | 2.77±11.23 | 0.068 |
d2 | 8.58±10.07 | 5.70±12.25 | 0.203 |
d3 | 8.80±11.17 | 6.25±10.78 | 0.256 |
d4 | 7.50±12.19 | 3.78±9.82 | 0.096 |
PLT (×109) | |||
d1 | 56.40±59.91 | 54.63±72.23 | 0.898 |
d2 | 62.30±69.89 | 51.37±59.40 | 0.403 |
d3 | 63.43±70.19 | 52.90±73.99 | 0.479 |
d4 | 54.50±72.18 | 47.50±73.07 | 0.638 |
dn = baseline − Cyclen. SD, standard deviation; WBC, white blood cell; NEU, neutrophilic granulocyte; HGB, hemoglobin; PLT, platelet.